High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo
- PMID: 24606906
- PMCID: PMC4099361
- DOI: 10.1016/j.cmet.2014.01.014
High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo
Abstract
In vitro studies have demonstrated a critical role for high-mobility group box 1 (HMGB1) in autophagy and the autophagic clearance of dysfunctional mitochondria, resulting in severe mitochondrial fragmentation and profound disturbances of mitochondrial respiration in HMGB1-deficient cells. Here, we investigated the effects of HMGB1 deficiency on autophagy and mitochondrial function in vivo, using conditional Hmgb1 ablation in the liver and heart. Unexpectedly, deletion of Hmgb1 in hepatocytes or cardiomyocytes, two cell types with abundant mitochondria, did not alter mitochondrial structure or function, organ function, or long-term survival. Moreover, hepatic autophagy and mitophagy occurred normally in the absence of Hmgb1, and absence of Hmgb1 did not significantly affect baseline and glucocorticoid-induced hepatic gene expression. Collectively, our findings suggest that HMGB1 is dispensable for autophagy, mitochondrial quality control, the regulation of gene expression, and organ function in the adult organism.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
All authors declare no conflict of interest.
Figures




References
-
- Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Opin Genet Dev. 2003;13:170–178. - PubMed
-
- Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S, Bianchi ME. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet. 1999;22:276–280. - PubMed
-
- Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–1252. - PubMed
-
- Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012;8:195–202. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
- R01 HL045095/HL/NHLBI NIH HHS/United States
- P30 DK041296/DK/NIDDK NIH HHS/United States
- U54 CA163111/CA/NCI NIH HHS/United States
- P60DK20541/DK/NIDDK NIH HHS/United States
- 5R01DK061498/DK/NIDDK NIH HHS/United States
- HL45095/HL/NHLBI NIH HHS/United States
- 1U01AA021912/AA/NIAAA NIH HHS/United States
- P60 DK020541/DK/NIDDK NIH HHS/United States
- R01 HL073029/HL/NHLBI NIH HHS/United States
- 5R01DK076920/DK/NIDDK NIH HHS/United States
- U01 AA021912/AA/NIAAA NIH HHS/United States
- HL73029/HL/NHLBI NIH HHS/United States
- R37 HL045095/HL/NHLBI NIH HHS/United States
- 5U54CA163111/CA/NCI NIH HHS/United States
- R01 DK061498/DK/NIDDK NIH HHS/United States
- R01 DK076920/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials